Home / Inspections / 1038720

FDA Inspection 1038720 — Teva Womens Health, LLC

Teva Womens Health, LLC — FEI 1526814

The FDA completed an inspection of Teva Womens Health, LLC on January 26, 2018 in Cincinnati, OH. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
January 26, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Cincinnati, OH (United States)

Facility

Other inspections at this facility

  • 1308790 (VAI Fri Mar 20 2026 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1205874 (NAI Fri Apr 07 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1116385 (NAI Wed Jan 08 2020 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 991799 (VAI Thu Nov 10 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 916349 (NAI Fri Feb 27 2015 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources